Trials / Completed
CompletedNCT05645991
Coconut Sugar Lowers Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
Effects of Novel Coconut Inflorescence Sap (CSP; COCOZEN) on Age-related Cardiovascular Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Ball State University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The goal of this intervention is to determine the efficacy of coconut sap powder (CSP) to lower arterial stiffness and blood pressure in middle-aged and older adults. Participants will be randomized to the CSP arm or Placebo arm of the study. Primary endpoints include: aortic stiffness assessed by carotid-femoral pulse wave velocity, resting brachial and (non-invasive) carotid blood pressure, and carotid stiffness (e.g. Beta stiffness index, Carotid compliance, Elastic modulus, Distensibility).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Coconut Sap Powder (CSP) | CSP was given once daily (1.5 g/day) for 8 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Capsules containing aspartame (1.5 g/day) were taken orally once daily for 8 weeks. |
Timeline
- Start date
- 2018-03-08
- Primary completion
- 2020-02-28
- Completion
- 2022-01-20
- First posted
- 2022-12-12
- Last updated
- 2022-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05645991. Inclusion in this directory is not an endorsement.